The Readout Loud
by STAT
April 12, 2024 3:02 am
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Recent Episodes
302: Vertex's big deal, biotech's red numbers, & an industry history lesson
1 week ago301: Biotech mega-rounds, a cancer vaccine setback & CEOs keep their promise
2 weeks ago300: What the mifepristone case means, GLP-1 skepticism, & Chinese biotech
3 weeks ago299: Live! From the STAT Breakthrough Summit East
4 weeks ago298: A dilemma in ALS, the first MASH drug, & why gene therapy is hard
1 month ago297: VC turmoil, GLP-1 competition, & the war on recovery
1 month ago296: Legal insider trading, booming biotech stocks, & the next GLP-1
2 months ago295: Humira’s legacy, CEO symbolism, and genomic surgery
2 months ago294: Pharma goes to Washington, Alnylam's future, & Gilead's dealmaking
2 months ago293: AI in medicine, detangling hype, and Icelandic DNA
2 months ago